<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Attorney At Law &#187; hemorrhagic</title>
	<atom:link href="http://www.attorneyatlaw.com/tag/hemorrhagic/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.attorneyatlaw.com</link>
	<description>Your source for legal news</description>
	<lastBuildDate>Mon, 19 Dec 2011 21:42:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Diabetes Medication Byetta Linked to Pancreatitis, FDA Orders Stronger Label Warning</title>
		<link>http://www.attorneyatlaw.com/2008/08/diabetes-medication-byetta-linked-to-pancreatitis-fda-orders-stronger-label-warning/</link>
		<comments>http://www.attorneyatlaw.com/2008/08/diabetes-medication-byetta-linked-to-pancreatitis-fda-orders-stronger-label-warning/#comments</comments>
		<pubDate>Tue, 19 Aug 2008 21:10:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Health & Medicine]]></category>
		<category><![CDATA[Legal News]]></category>
		<category><![CDATA[amylin pharmaceuticals]]></category>
		<category><![CDATA[byetta]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[hemorrhagic]]></category>
		<category><![CDATA[necrotizing pancreatitis]]></category>

		<guid isPermaLink="false">http://www.attorneyatlaw.com/?p=86</guid>
		<description><![CDATA[Byetta, a Type 2 diabetes drug made by Amylin Pharmaceuticals, Inc., has been linked to six cases of hemorrhagic or necrotizing pancreatitis. Two patients have died and four others are recovering after being hospitalized, according to the U.S. Food and Drug Administration. The recent incidents have prompted the FDA to develop stronger, more prominent warnings for the product’s label to alert consumers about the risk of acute hemorrhagic or necrotizing pancreatitis.  Physicians are being cautioned to consider anti-diabetic therapies other &#8230;]]></description>
		<wfw:commentRss>http://www.attorneyatlaw.com/2008/08/diabetes-medication-byetta-linked-to-pancreatitis-fda-orders-stronger-label-warning/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

